Table 5. Comparison of PMTCT service coverage in the community survey compared to results of a simultaneous survey in corresponding facilities [15].
| Country (Site) | Community | Facility | ||
| n/N | Percent Coverage (95% CI) | n/N | Percent Coverage (95% CI) | |
| Cameroon (1) | 23/41 | 56.1 (39.7–71.5) | 186/262 | 71.0 (65.1–76.4) |
| Cameroon (2) | 18/35 | 51.4 (34.0–68.6) | 61/80 | 76.3 (65.4–85.1) |
| Cameroon (3) | 20/28 | 71.4 (51.3–86.8) | 135/218 | 61.9 (55.1–68.4) |
| Côte D'Ivoire (1) | 0/18 | 0.0 (0.0–18.5) | 26/116 | 22.4 (15.2–31.1) |
| South Africa (1) | 51/124 | 41.1 (32.4–50.3) | 89/177 | 50.3 (42.7–57.9) |
| South Africa (2) | 53/91 | 58.2 (47.4–68.5) | 124/195 | 63.6 (56.4–70.3) |
| South Africa (3) | 12/35 | 34.3 (19.1–52.2) | 51/109 | 46.8 (37.2–56.6) |
| South Africa (4) | 34/116 | 29.3 (21.2–38.5) | 76/186 | 40.9 (33.7–48.3) |
| Zambia (1) | 14/30 | 46.7 (28.3–65.7) | 22/35 | 62.9 (44.9–78.5) |
| Zambia (2) | 57/105 | 54.3 (44.3–64.0) | 72/133 | 54.1 (45.3–62.8) |
| Zambia (3) | 6/14 | 42.9 (17.7–71.1) | 32/54 | 59.3 (45.0–72.4) |
| Zambia (4) | 22/53 | 41.5 (28.1–55.9) | 53/101 | 52.5 (42.3–62.5) |
| Zambia (5) | 25/49 | 51.0 (36.3–65.6) | 42/62 | 67.7 (54.7–79.1) |
| Zambia (6) | 38/85 | 44.7 (33.9–55.9) | 83/142 | 58.5 (49.9–66.7) |
| Zambia (7) | 44/77 | 57.1 (45.4–68.4) | 115/167 | 68.9 (61.2–75.8) |
| Zambia (8) | 23/49 | 46.9 (32.5–61.7) | 83/164 | 50.6 (42.7–58.5) |
| Crudea mean | 440/950 | 46.3 (43.2–49.5) | 1,250/2,201 | 56.8 (54.7–58.9) |
Coverage defined as the proportion of children born to HIV-positive mothers in whom any ARV drug is reported to have been used during pregnancy.
a
Not adjusted to account for clustering within communities or countries.